"...simply walk away from hundreds of millions of dollars..." Well, if it's a choice between walking away from money poorly invested and continuing to flush money down into bottomless well of losses, which would you choose?
Not to mention, even if SNY cancels the deal, MNKD will still owe them whatever the current balance on the 175 million dollar loan. So SNY recoups at least some of their loss.
No, studies funded by MNKD or SNY don't count. I'm not really trying to argue any point. I'm trying to understand Schimmer's rather radical change in attitude. Before, he blamed things on spirometry and on, based on a survey, endos not knowing about afrezza. Now he doesn't mention spirometry, apparently is satisfied that docs know about afrezza, surveys only five of them and flushes MNKD down the toilet. His final conclusion is that docs aren't interested in using it. In other words, spirometry is a non-issue now simply because docs aren't going to be prescribing afrezza. I wonder if he's thinking along Feurstein's line -- that SNY will dump afrezza at the first opportunity.
"once they've decided to prescribe Afrezza,"??? Well, you see, that's just it. My impression, like Schimmer's, is that endos simply don't like the drug and don't plan on using it. Hence, SNY is putting no more effort into marketing spirometers to endos simply because there is no reason to. Have you seen any really favorable articles written by endos?
"Reportedly, primary care physicians typically..."? Really? What percentage? Can you support your assertion with real statisitcs?
"There may be other actions too..."? Really? The sun "may" rise in the west tomorrow, but I'd just as soon not bet on it. That was my original question -- what EXACTLY has SNY done to solve the alleged spirometry problem?
Has it crossed anyone's mind that perhaps spirometry never really was a problem? That the endos simply didn't like afrezza and weren't planning on using it anyway? I noticed that Stillman didn't bring up the spirometry issue in his "survey," whereas before he said -- as I recall -- that it was a "primary" issue. It seems odd that he would so casually dismiss it now.
The link takes you to nothing more than a product information page, ditto for the link on the afrezzapro page. And THAT is ALL they're doing? It looks more like nothing more than old fashioned "bait and switch" to me -- using afrezza to promote their own spirometers than doing anything to boost spirometry use in docs' offices.
Thanks for the reply but it really doesn't address the central issue of what Sanofi actually did to resolve the issue. What exactly did they do? No one seems to know. I sure can't find that they have done anything.
Seems like a few months ago, it was a major issue, and then MNKD said SNY had done "something" about it, but didn't say -- typical for MNKD - what! Has SNY simply given up marketing to endos? I really don't see what SNY could do to overcome the problem otherwise.
Do you understand what hypoglycemia is? If Matt had gotten in trouble with hypoglycemia then a "correcting" dose of afrezza probably would have killed him.
Have you heard of something called "Bagholders Affective Syndrome"? I strongly suggest you do some research into it before you lose TOO much more money.
I don't see out pointing out someone is a liar and a fraud could be construed as "bashing" -- as long as it's accurate.
Funny that mine gets deleted as well when I try and explain. Yahoo simply rejects pretty much any post remotely smacking of a link to some other website. It won't even let me post "h.t.youknowwhat.p." Most people get around it by dropping that part and substituting "dot" in the address.
You have to undderstand that most MNKD shareholders suffer from "Bagholders Affective Disorder," which causes them to suffer from various delusions to the effect that there is SOME hope SOMEWHERE for their stock. Hence, the reality of the US reaction to afrezza forces the afflicted to seek consolation that someplace might exist where afrezza might NOT be rejected..
I'd be willing to bet for MNKD BAGHOLDERS, a drop of a HUNDRED per cent wouldn't be "significant." They'd find SOME way of spinning it so they wouldn't have to face reality!.
Maybe you should take a hint? Or take whatever med you obviously must need for your MNKD OCD. Besides, who cares? It's been established quite THOROUGHLY that SNY has not applied for EU approval. The "UK application" you refer to is ANCIENT history and nothing has come of it since.
"train wreck"??? Personally, all I see is the "wreck" with hardly any measureable "motion" whatsoever! It practically defines "inertia"!
The REAL difference is that heartmate actually DOES something to improve cardiac output while all c-pulse does is "jacks___"!